PBi

About:

PBi is a biotechnology company that provides advance methods for detecting the disease early and treating affected patients with precision.

Website: https://www.pbimmunomics.com/

Description:

PBimmunomics’ ambition is to advance methods for detecting disease early and treating affected patients with precision. We developed the Episcan platform to provide researchers with unique antibody binding profiles specific for individuals and diseases. Antibody binding profiles deliver the essential data to drive breakthroughs in disease diagnostics and treatments and develop clinical tests similar to your everyday pregnancy test. Additionally, our research team is applying Episcan to develop clinical point of care tests for Type 2 diabetes, cardiovascular disease, cancers, and other autoimmune diseases. PBimmunomics’ revolutionary Episcan platform enables precision medicine to be cost-effective and easy to apply.

Total Funding Amount:

1.2M EUR

Headquarters Location:

Tallinn, Harjumaa, Estonia

Founded Date:

2010-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2016-05-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai